
Faisal Qutbee
Entrepreneur and technology leader focused on AI, technology, healthcare and longevity. Contributed to the Digital Dubai initiative behind the city's paperless transformation, and to large-scale government projects in Abu Dhabi.
Biovity is an AI-powered health risk intelligence platform for clinics, longevity centres and healthcare professionals. It brings reports, biomarkers, lifestyle and wearable data into a single profile, and shows where further attention may be warranted.
Client health profileSample data
Entrepreneur and technology leader focused on AI, technology, healthcare and longevity. Contributed to the Digital Dubai initiative behind the city's paperless transformation, and to large-scale government projects in Abu Dhabi.

Heads the Department of Clinical Anatomy & Histology at SKIMS, with clinical training across surgery, radiology and dermatology.
Clinics and longevity centres collect more data per client than ever. Most of it arrives as separate files, in different formats, from different sources.
Lab reports, biomarkers, lifestyle information and wearable data live in separate places and formats.
Professionals spend time collating results before they can start interpreting them.
Gradual shifts across months of results are hard to see when each report is read on its own.
Every client file looks different, which makes reviews slower and harder to standardise.
Biovity consolidates a client's health information, identifies potential risk patterns, highlights changes over time and presents structured insights, so professionals can focus their attention where it matters.
Health reports, biomarkers, lifestyle information and wearable data in one profile.
Potential risk patterns across related markers and data sources.
What has moved since the last review, and in which direction.
Structured, source-linked summaries ready for professional review.
The professional stays in charge. Biovity surfaces what may warrant further assessment. Clinical judgement and every decision remain with the healthcare professional.

Clients / A-1042 / ProfileSample data46 · Male · 6 reports since 2023 · Last review 12 Aug
Clients / A-1042 / Risk patternsSample dataThree related markers above reference range across the last two reports. Source: Lab report, 02 Sep.
hs-CRP trending upward across three reports, alongside reduced HRV.
Below range in the latest report; previously within range.
Clients / A-1042 / TrendsSample data
Clinic workspace / Review queueSample data| Client | Latest data | Change | Status |
|---|---|---|---|
| A-104246 · M | Lab report · 3d | New cardiometabolic pattern | Review |
| B-221752 · F | Wearable sync · 1d | HRV down 15% | Watch |
| C-038838 · M | Lab report · 5d | Vitamin D back in range | Improved |
| D-119061 · F | Questionnaire · 6d | No new patterns | Stable |
Ongoing, data-rich client programmes.
Repeated testing and lifestyle-led care.
Annual and periodic assessments at scale.
Population-level health programmes.
Coaches, nutritionists and physicians.
Reports are consolidated before the professional opens the file.
The same structured view for every client and every practitioner.
Changes over time are surfaced, not discovered by chance.
Clear, branded summaries keep clients involved between visits.
Global clinical decision support software market, 2024. Conservative estimate; other reports go up to $10.8B.
~104,000 functional-medicine-trained clinicians × $1,800/yr, plus ~4,200 longevity & health-optimisation clinics × $10,800/yr.
About 1,940 paying practitioners, clinics and groups by year 5, under 4% of the reachable market (see revenue projection).
Sources: Global Wellness Institute, Global Wellness Economy Monitor 2024 · McKinsey, Future of Wellness 2024 · Global Industry Analysts, clinical decision support systems (via GII) · Institute for Functional Medicine, 2025 impact report · Market Intelo (clinic count, broad definition). SAM and SOM are Biovity estimates using proposed pricing.
Proposed tiers. Pricing and packaging to be finalised.
| Paying customers | Y1 | Y2 | Y3 | Y4 | Y5 |
|---|---|---|---|---|---|
| Practitioners$150 / month | 60 | 200 | 500 | 900 | 1,400 |
| Clinics$900 / month avg. | 15 | 60 | 160 | 320 | 520 |
| Enterprise groups$40,000 / year avg. | 0 | 2 | 6 | 12 | 20 |
| ARR | $0.27M | $1.09M | $2.87M | $5.56M | $8.94M |
Data is encrypted in transit and at rest.
Client data is added and shared only with consent.
Each practitioner sees only the clients they are permitted to.
Every view and change is logged.
Every pattern links to the markers, values and reports behind it.
Insights inform professionals. They never act on their own.
Fund product, integrations and go-to-market with clinics.
Early access and direct input into the product.
Labs, wearable companies and health platforms.
Use of funds: product and AI engineering · integrations · clinic acquisition · security and compliance.

Client profiles, values and workspace figures shown are illustrative sample data. Biovity is a health risk intelligence platform for healthcare professionals. It does not diagnose, treat or provide medical decisions; all clinical decisions remain with qualified professionals. Pricing tiers are proposed and subject to change.